The studies carried out to date on vulvodynia treatment with botulinum neurotoxin type A
(BoNT/A) have followed generic injection protocols and reported contradictory outcomes on …

In this case study, a 68-year-old woman with anal incontinence (AI) and vaginal atrophy
(VVA), who did not respond to traditional treatments such as pelvic floor exercises or …

After the age of 50, the frequency of partnered sex decreases, and coping strategies for
dealing with this change may vary as people reach later adulthood. To date, little is known …

Background This study explores the characteristics of people aged 50+ who use the internet
for sexual purposes. Methods The markers of sexual expression in association with online …

Objective To develop a model to identify women likely to be severely impacted by
vulvovaginal atrophy (VVA), based on their experience of symptoms and non-clinical factors …

Objective: To describe the impact of genitourinary syndrome symptoms on daily activities
and well-being in peri-and postmenopausal women living in an urban area. Materials and …

Цель исследования: оценить эффективность негормональной терапии атрофического
вагинита (АВ) у женщин в постменопаузе. Материал и методы: выполнено пилотное …

Background Genitourinary syndrome of menopause (GSM) is a common condition, yet there
is no defined, objective, and reproducible intervention with which to make a diagnosis …

Актуальность: Стандартом лечения женщин с генитоуринарным менопаузальным
синдромом является местная гормональная терапия эстриолом. Необходимые дозы …

Puntos para una lectura rápida• En España, en las mujeres posmenopáusicas y en lo
referente al SGM, el síntoma más frecuente es la sequedad vaginal (81%). Solo un 15% de …